RENO,
NV -- (MARKET WIRE) -- 12/20/2005 -- Altair Nanotechnologies
Inc. (NASDAQ: ALTI ),
announced today that it has been selected for inclusion
in a new nanotechnology index launched by San Francisco-based
Global Crown Capital. The new index, The Global Crown
Capital Nanotechnology Index ™, is a price-weighted
index currently composed of nineteen pure play nanotechnology
stocks that represent the emerging nanotechnology
industry.
"The Global Crown Capital Nanotechnology index is
innovative and unique to other indexes covering nanotechnology," commented
Altairnano's CEO, Alan J. Gotcher Ph.D. "The components
in this index must have a significant share of their
total revenue generated from involvement in the research,
development and manufacturing of nanomaterials and
nano-devices covering a broad spectrum of industries.
This eliminates large Fortune companies and allows
investors to focus on pure nanotech companies. Altair's
hard work and commitment to its R&D efforts,
product development, and manufacturing of nanomaterials
is becoming recognized by the investing community," added
Gotcher.
In
addition to Altair's inclusion in The Global Crown
Capital Nanotechnology Index, Altair is a component
of the Punk Ziegel Nanotech Index, the Merrill
Lynch Nanotech Index, the Lux Nanotech Index™ and
the Innovest Strategic Value Advisors Nanotech
Index. Altair's common stock, symbol ALTI, is also
a component of the PowerShares Lux Nanotech ETF
(exchange traded fund), symbol (AMEX: PXN ),
which trades on the American Stock Exchange.
ABOUT ALTAIR NANOTECHNOLOGIES INC.
Altairnano is a leading supplier and innovator of
advanced ceramic nanomaterial technology. Based in
Reno, Nevada, Altairnano has assembled a unique team
of materials scientists who, coupled in collaborative
ventures with industry partners and leading academic
centers, have pioneered an array of intellectual
property and products.
Altairnano's robust proprietary technology platforms
produce a variety of crystalline and non-crystalline
nanomaterials of unique structure, performance, quality
and cost. The company has scalable manufacturing
capability to meet emerging nanomaterials demands.
Altairnano's two divisions, Life Sciences and Performance
Materials, are focused on applications where its
nanotechnology may enable new high growth markets.
The Life Sciences Division is pursuing market applications
in pharmaceuticals, drug delivery, dental materials
and other medical markets. The Performance Materials
Division is focused on market applications in advanced
materials for paints and coatings; air and water
treatment and alternative energy, including new lithium
ion battery electrode materials. For additional information
on Altairnano and its nanomaterials, visit www.altairnano.com
|
